ABSORB STEMI: the TROFI II Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 191 participants.
Also called NCT01986803
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 191 participants
- Sponsor
- Registry
-
NCT01986803
-
- Other papers using this trial's data
- Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark, Netherlands, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01986803. Randomized; single masking; primary purpose treatment. Start 2014-01-06 (actual); primary completion 2015-04-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ABSORB STEMI: the TROFI II Study
- Condition
- Acute ST Segment Elevation Myocardial Infarction
- Intervention (Device)
- Percutaneous Coronary Intervention
- Lead sponsor
- ECRI bv
- Collaborator
- Abbott Medical Devices
- Collaborator
- Terumo Europe N.V.
Record details
- Record id
cardio:ct-nct01986803- Content hash
531bd9d9fd9923b59d9ee09943ec064a262b21b7be5ec05b50951ef27e27a6bf